Nuwellis Stock In The News

NUWE Stock  USD 1.38  0.02  1.43%   
Our overall analysis of Nuwellis' news coverage and content from conventional and social sources shows investors' bearish mood towards Nuwellis. The specific impact of Nuwellis news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Nuwellis' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Nuwellis headlines in addition to utilizing other, more conventional financial analysis modules. Check out Nuwellis Backtesting and Nuwellis Hype Analysis.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.

Nuwellis Today Top News and Investor Outlook

Yahoo News
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
https://finance.yahoo.com/news/nuwellis-davita-extend-supply-collaboration-130000278.html
 Bullish
Macroaxis News: globenewswire.com
New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
https://www.globenewswire.com/news-release/2023/11/28/2786898/26106/en/New-Real-World-Data-Highlight-the-Clinical-Benefits-of-Ultrafiltration-Therapy-with-Hematocrit-Monitoring-for-Pediatric-Patients.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/11/14/2780569/26106/en/Nuwellis-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
https://www.globenewswire.com/news-release/2023/11/07/2775028/26106/en/Nuwellis-Inc-Announces-Third-Quarter-2023-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis Announces Board of Directors Transition
https://www.globenewswire.com/news-release/2023/11/01/2771108/26106/en/Nuwellis-Announces-Board-of-Directors-Transition.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
https://www.globenewswire.com/news-release/2023/10/31/2770127/26106/en/Nuwellis-Strategic-Partner-SeaStar-Medical-Receives-FDA-Approvable-Letter-for-Its-Pediatric-Selective-Cytopheretic-Device.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis, Inc. To Announce Third Quarter 2023 Financial Results on November 7, 2023
https://www.globenewswire.com/news-release/2023/10/18/2762756/26106/en/Nuwellis-Inc-To-Announce-Third-Quarter-2023-Financial-Results-on-November-7-2023.html
 Neutral
Macroaxis News: globenewswire.com
Nuwellis Announces Closing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
https://www.globenewswire.com/news-release/2023/10/17/2761919/26106/en/Nuwellis-Announces-Closing-of-2-25-Million-Public-Offering-of-Series-J-Convertible-Redeemable-Preferred-Stock-and-Warrants.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
https://www.globenewswire.com/news-release/2023/10/13/2759945/26106/en/Nuwellis-Announces-Pricing-of-2-25-Million-Public-Offering-of-Series-J-Convertible-Redeemable-Preferred-Stock-and-Warrants.html
 Bullish
Macroaxis News: globenewswire.com
Nuwellis Provides Regulatory Update on S...
https://www.globenewswire.com/news-release/2023/10/10/2757403/26106/en/Nuwellis-Provides-Regulatory-Update-on-SeaStar-Medical-s-Selective-Cytopheretic-Device-Use-in-Pediatric-Acute-Kidney-Injury-Under-a-Humanitarian-Device-Exemption.html
 Bullish

Nuwellis Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Nuwellis and other traded companies coverage with news coverage. We help investors stay connected with Nuwellis headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Nuwellis Stock performance. Please note that trading solely based on the Nuwellis hype is not for everyone as timely availability and quick action are needed to avoid losses.
Nuwellis' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Nuwellis investors visualize upcoming and past events in order to time the market based on Nuwellis noise-free hype analysis.
Nuwellis stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Nuwellis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Nuwellis that are available to investors today. That information is available publicly through Nuwellis media outlets and privately through word of mouth or via Nuwellis internal channels. However, regardless of the origin, that massive amount of Nuwellis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nuwellis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nuwellis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nuwellis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nuwellis alpha.

Nuwellis Largest EPS Surprises

Earnings surprises can significantly impact Nuwellis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-05
2023-12-31-1.39-1.56-0.1712 
2024-05-07
2024-03-31-1.06-0.60.4643 
2023-11-07
2023-09-30-3.11-1.811.341 
2023-05-09
2023-03-31-3.79-5.76-1.9751 
2024-11-11
2024-09-30-1.281.743.02235 
2022-11-08
2022-09-30-32-37.0-5.015 
View All Earnings Estimates

Nuwellis Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Nuwellis Stock. Current markets are slightly bearish. About 58% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
20th of November 2024
Nuwellis Stock Spikes After Reimbursement Hike Retails Upbeat - MSN
at news.google.com 
insidermonkey News
12th of November 2024
Nuwellis, Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
zacks News
6th of November 2024
Tandem Diabetes Care, Inc. Reports Q3 Loss, Tops Revenue Estimates
at zacks.com 
Yahoo News
4th of November 2024
Nuwellis Stock Soars 121 percent on Major Increase in Reimbursement for Aquadex System
at finance.yahoo.com 
Yahoo News
1st of November 2024
Nuwellis Announces Preliminary Results for Third Quarter of 2024
at finance.yahoo.com 
Macroaxis News: globenewswire.com
25th of September 2024
Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference
at globenewswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nuwellis in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nuwellis' short interest history, or implied volatility extrapolated from Nuwellis options trading.
When determining whether Nuwellis is a strong investment it is important to analyze Nuwellis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuwellis' future performance. For an informed investment choice regarding Nuwellis Stock, refer to the following important reports:
Check out Nuwellis Backtesting and Nuwellis Hype Analysis.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuwellis. If investors know Nuwellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuwellis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(60.77)
Revenue Per Share
48.483
Quarterly Revenue Growth
0.057
Return On Assets
(0.79)
Return On Equity
(9.87)
The market value of Nuwellis is measured differently than its book value, which is the value of Nuwellis that is recorded on the company's balance sheet. Investors also form their own opinion of Nuwellis' value that differs from its market value or its book value, called intrinsic value, which is Nuwellis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuwellis' market value can be influenced by many factors that don't directly affect Nuwellis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuwellis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuwellis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuwellis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.